Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px
Document › Details

Advanced Chemistry Development, Inc. (ACD/Labs). (10/24/18). "Press Release: ACD/Labs Releases Updates to Its Foundational Spectrus and Percepta Platforms". Toronto.

Organisation Organisation Advanced Chemistry Development Inc. (ACD/Labs)
  Group Advanced Chemistry Development (ACD/Labs) (Group)
Products Product ACD/Spectrus analytical chemistry software platform
  Product 2 ACD/Percepta software platform
Person Person Anderson, Andrew (ACD/Labs 201512– VP Business Development before PepsiCo + Symyx + ACD/Labs + Pfizer)
     


The release of ACD/Labs' v2018.1 software includes major enhancements to its analytical knowledge management solutions for pharmaceutical development, MS and NMR dereplication workflows, and chromatography offerings.


ACD/Labs, an informatics company that develops and commercializes analytical and chemical knowledge management solutions in support of R&D, today announced significant updates across its ACD/Spectrus and Percepta platforms. Version 2018.1 delivers greater functionality to all ACD/Labs products, including key tools for analytical and process chemists in pharmaceutical development, NMR spectroscopists, mass spectrometrists, plus LC and GC method development specialists.

"Scientific organizations expect a wealth of innovative capabilities in the applications they use to help them solve their most complex scientific challenges. But, they also expect those applications to be continually updated and improved," said Andrew Anderson, Vice President of Innovation and Informatics Strategy at ACD/Labs. "This software release offers a wealth of new and valuable functionality—we believe it represents a commitment to our customers to help them improve their productivity, provide deep scientific insight, and facilitate decision-making."

ACD/Labs' v2018.1 software release includes the following updates:

Analytical Knowledge Management in Pharmaceutical Development—taking into account specific feedback from customers, v2018.1 of LuminataMetaSense™ include multiple requested features for both products. Luminata now includes automated calculation of impurity carryover across stages, and improved handling of process schema imported from third-party drawing packages—including reagents and reactants. MetaSense users can now identify a greater number of metabolites through the addition of user-defined reactions, expand the scope of projects by analyzing data from multiple different species (human, mouse, rat, dog) together, and accelerate reporting by utilizing customizable reporting templates.

NMR and MS Dereplication—two new features have been introduced that streamline identification of "known unknowns" in both NMR and MS analysis. The Known Structure Identification NMR workflow, available as an add-on to both ACD/NMR Workbook Suite and ACD/Spectrus Processor, quickly determines whether experimental 13C spectra match predicted signals of known compounds. Similarly, improvements to the Intelligent Component Recognition workflow in ACD/MS Workbook Suite enable efficient identification of LC and GC known unknowns through batch spectral searching. Additional key NMR and MS updates include improved peak picking and multiplet assignment accuracy for 13C NMR spectra of fluorinated compounds, and upgraded MS Tree control to better visualize multiple MS spectra together.

Usability Improvements to Method Development Solutions—in response to customers communicating their chromatography software needs, ACD/Labs has simplified the v2018.1 product line by consolidating functionality from across various chromatography applications into two comprehensive method development and optimization solutions: the improved ACD/AutoChrom, and the new ACD/Method Selection Suite. Particularly, Method Selection Suite combines physicochemical property predictions with method optimization tools to define better starting conditions, estimate retention times, and optimize key separation parameters, all according to quality by design (QbD) principles.

Physicochemical and ADME/Tox Property Prediction—v2018.1 of the Percepta platform, which provides in silico predictions of physchem, ADME, and toxicity properties, includes significant improvements to the logP structure database (>1700 compounds added) to deliver more reliable and accurate logP estimates for novel compounds. Plus, this expansion also improves prediction tools that require logP—logD, oral bioavailability, blood-brain barrier penetration, and more.

For more information on ACD/Labs' v2018.1 software updates, please visit www.acdlabs.com/whatsnew.


About Advanced Chemistry Development, Inc.

ACD/Labs is a leading provider of scientific informatics technologies to R&D organizations that rely on analytical data and molecular information for decision-making, problem-solving, and product lifecycle control. Our software automates and accelerates molecular characterization, product development, and knowledge management. We integrate with existing informatics systems and undertake custom projects including enterprise-level automation.

ACD/Labs solutions are used globally in a variety of industries including pharma/biotech, chemicals, consumer goods, agrochemicals, petrochemicals, and academic/government institutions. We provide worldwide sales and support, and more than 20 years of experience and success helping organizations accelerate R&D and leverage corporate intelligence. For more information, please visit www.acdlabs.com. Follow us on Twitter @ACDLabs.

Questions? We have answers

If you can't find what you're looking for, ask a real person. E-mail us to inquire further about this press release.

Contact: media@acdlabs.com
P: (416) 368-3435
F: (416) 368-5596

   
Record changed: 2018-11-03

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

More documents for Advanced Chemistry Development (ACD/Labs) (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px




» top